KWM
INSM icon

Kingsview Wealth Management’s Insmed INSM Stock Holding History

Kingsview Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
2,147
+58
+3% +$7.02K ﹤0.01% 1303
2026
Q1 		$342K Buy
2,089
+18
+0.9% +$2.77K ﹤0.01% 1025
2025
Q4 		$360K Sell
2,071
-250
-11% -$45.6K 0.01% 964
2025
Q3 		$334K Buy
2,321
+60
+3% +$7.35K 0.01% 927
2025
Q2 		$228K Buy
+2,261
New +$173K ﹤0.01% 1060

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Kingsview Wealth Management's INSM Position: Q2 2026 in Review

Kingsview Wealth Management increased its Insmed (INSM) stake by 2.8% in Q2 2026, buying an estimated $7.02K and bringing the position to 2,147 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1303.

Kingsview Wealth Management first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $360K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Kingsview Wealth Management held 2,147 shares of Insmed worth $229K as of Q2 2026.
  • Kingsview Wealth Management bought 58 Insmed shares in Q2 2026, an estimated $7.02K.
  • Insmed made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #1303 holding.
  • Kingsview Wealth Management first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • Kingsview Wealth Management's Insmed position peaked at $360K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.